Schizophrenia Market Research Reports

Schizophrenia Market Research

Schizophrenia is a severe, lifelong brain disorder. People who have it may hear voices, see things that aren’t there or believe that others are reading or controlling their minds.

Research indicates that the global schizophrenia market was worth $6.7bn in 2009. The global Schizophrenia therapeutics market is forecast to decline with a CAGR of (3.7%) to reach $5.1bn by 2017. This decline in the market is primarily attributed to the release of generics of some of the leading products during the period 2011-2014. The therapeutic market for schizophrenia is expected to decline form 2011 till mid 2014 due to the patent expiry of major marketed drugs such as Zyprexa, Abilify, Seroquel and Geodon. However in the late 2014, the situation is set to improve. There is a huge unmet need in the current market in terms of safety and efficacy. Furthermore, a low treatment seeking rate and low patient compliance rate are likely to act as a barrier to market growth.

The Schizophrenia drug therapy market research report provides insight into the pipeline status of schizophrenia therapeutics by company and by stage, as well as a summary of the latest news and developments in this area. In addition to new developments and disease specific pipeline projects, the listed reports also contain extensive information in tabular format on a company’s full product pipeline, and products by phase of development with regard to the therapy area. The study also helps in keeping track of the industry-specific competitors and partners by better understanding their product pipeline.

The study basically aims at providing a comprehensive overview of the on-goings of the schizophrenia drugs & therapy market.

 



 

View More
TITLE Actions
Global Schizophrenia Therapeutic Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. The mainstay of schizophrenia treatment is antipsychotic medication, along with counselling, job training and social rehabilitation....

Global Schizophrenia Treatments Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. The schizophrenia treatment market is expected to witness a high growth over the forecast period owing to the increasing incidence of schi...

Global Schizophrenia Therapeutics Market Size, Status and Forecast 2019-2025
Published in Jan 2019 | US $ 3900 Onwards | By QYResearch Group

Schizophrenia therapeutics are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition. The second-generation antipsychotic drugs segment...

Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Insight, 2019
Published in Jan 2019 | US $ 1500 Onwards | By Delve Insight

"Cognitive Impairment Associated With Schizophrenia (CIAS) - Pipeline Insight, 2019” report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Cognitive Impairment Associ...

Schizophrenia - Epidemiology Forecast to 2028
Published in Jan 2019 | US $ 3250 Onwards | By Delve Insight

DelveInsight's "Schizophrenia - Epidemiology Forecast, 2028” report provides a comprehensive analysis of the Schizophrenia epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028. ...

Schizophrenia - Market Insight, Epidemiology and Market Forecast - 2028
Published in Jan 2019 | US $ 6250 Onwards | By Delve Insight

DelveInsight's "Schizophrenia - Market Insight, Epidemiology and Market Forecast - 2028" report provides a detailed analysis of the Schizophrenia epidemiology and market outlook for the 7MM. Markets Covered - United States...

Global and Chinese Schizophrenia Therapeutic Industry, 2018 Market Research Report
Published in Jan 2019 | US $ 3000 Onwards | By Prof Research

The 'Global and Chinese Schizophrenia Therapeutic Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Schizophrenia Therapeutic industry with a focus on the Chinese market. The report pr...

Global and Chinese Schizophrenia Treatments Industry, 2018 Market Research Report
Published in Jan 2019 | US $ 3000 Onwards | By Prof Research

The 'Global and Chinese Schizophrenia Treatments Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Schizophrenia Treatments industry with a focus on the Chinese market. The report prov...

Global and Chinese Schizophrenia Therapeutics Industry, 2018 Market Research Report
Published in Dec 2018 | US $ 3000 Onwards | By Prof Research

The 'Global and Chinese Schizophrenia Therapeutics Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Schizophrenia Therapeutics industry with a focus on the Chinese market. The report ...

Global and Chinese Schizophrenia Drugs Industry, 2018 Market Research Report
Published in Dec 2018 | US $ 3000 Onwards | By Prof Research

The 'Global and Chinese Schizophrenia Drugs Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Schizophrenia Drugs industry with a focus on the Chinese market. The report provides key s...

Global Schizophrenia Therapeutic Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Published in Nov 2018 | US $ 3480 Onwards | By Global Info Research

Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. Scope of the Report: The mainstay of schizophrenia treatment is antipsychotic medication, along with counselling, job train...

Global Schizophrenia Treatments Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Published in Nov 2018 | US $ 3480 Onwards | By Global Info Research

Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. Scope of the Report: The schizophrenia treatment market is expected to witness a high growth over the forecast period owing...

Global Schizophrenia Drugs Market Data Survey Report 2025
Published in Nov 2018 | US $ 1500 Onwards | By HeyReport

Summary The global Schizophrenia Drugs market will reach Volume Million USD in 2018 with CAGR xx% 2018-2025. The main contents of the report including: Global market size and forecast Regional market size, production data...

Schizophrenia - Pipeline Review, H2 2018
Published in Oct 2018 | US $ 2000 Onwards | By Global Markets Direct

Schizophrenia - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia - Pipeline Review, H2 2018, provides an overview of the Schizophrenia (Centra...

Global Schizophrenia Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
Published in Oct 2018 | US $ 3480 Onwards | By Global Info Research

Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to understand reality. Common symptoms include false beliefs, unclear or confused thinking, hearing voices that others do not, reduced social engagement and emot...

Global Schizophrenia Therapeutic Market Growth (Status and Outlook) 2018-2023
Published in Oct 2018 | US $ 3660 Onwards | By LP Information INC

Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. The mainstay of schizophrenia treatment is antipsychotic medication, along with counselling, job training and social rehabilitation....

Global Schizophrenia Treatments Market Growth (Status and Outlook) 2018-2023
Published in Oct 2018 | US $ 3660 Onwards | By LP Information INC

Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. The schizophrenia treatment market is expected to witness a high growth over the forecast period owing to the increasing incidence of schi...

Global Schizophrenia Partnering 2012 to 2018
Published in Oct 2018 | US $ 1995 Onwards | By Current Partnering

"Delivery of this report will take 1-3 days after purchase." Provides understanding and access to the schizophrenia partnering deals and agreements entered into by the worlds leading healthcare companies. The Global Sch...

Global Schizophrenia Treatments Market Size, Status and Forecast 2018-2025
Published in Sep 2018 | US $ 3900 Onwards | By QYResearch Group

Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. The schizophrenia treatment market is expected to witness a high growth over the forecast period owing to the increasing incidence of schi...

Global Schizophrenia Therapeutic Market Size, Status and Forecast 2018-2025
Published in Sep 2018 | US $ 3900 Onwards | By QYResearch Group

Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. The mainstay of schizophrenia treatment is antipsychotic medication, along with counselling, job training and social rehabilitation....

We are on:

Need Help?